Mr. Speaker, a negotiation team was assembled in June 2020, led by Public Services and Procurement Canada, to initiate negotiations with leading vaccine suppliers. During these early engagements, both Public Services and Procurement Canada and the Public Health Agency of Canada raised domestic options for manufacturing vaccines. The specific details of the negotiations cannot be disclosed as it is confidential commercial information.
After reviewing the options, the manufacturers concluded that biomanufacturing capacity in Canada at the time of contracting was too limited to justify the investment of capital and expertise required to start manufacturing in Canada.